1 |
Afify, S., Rapp, U. R. and Hogger, P. 2004. Validation of a liquid chromatography assay for the quantification of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serum. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 809, 99-103.
DOI
|
2 |
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., Rolland, F., Demkow, T., Hutson, T. E., Gore, M., Freeman, S., Schwartz, B., Shan, M., Simantov, R. and Bukowski, R. M. 2007. Sorafenib in advanced clear-cell renal- cell carcinoma. N. Engl. J. Med. 356, 125-134.
DOI
ScienceOn
|
3 |
Hotte, S. J. and Hirte, H. W. 2002. BAY 43-9006: early clinical data in patients with advanced solid malignancies. Curr. Pharm. Des. 8, 2249-2253.
DOI
ScienceOn
|
4 |
KFDA Guidance for Industry, Bioanalytical method validation, National Institute of Toxicology Department. 2003. http://www.kfda.go.kr/
|
5 |
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J. F., de Oliveira, A. C., Santoro, A., Raoul, J. L., Forner, A., Schwartz, M., Porta, C., Zeuzem, S., Bolondi, L., Greten, T. F., Galle, P. R., Seitz, J. F., Borbath, I., Haussinger, D., Giannaris, T., Shan, M., Moscovici, M., Voliotis, D. and Bruix, J. 2008. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 359, 378-390.
DOI
ScienceOn
|
6 |
Park, D. J. and Kim, W. M. 2009. The rapid determination of gemcitabine by reversed-phase ultra-performance liquid chromatography. J. Life Sci. 19, 1698-1704.
DOI
|
7 |
Sparidans, R. W., Vlaming, M. L., Lagas, J. S., Schinkel, A. H., Schellens, J. H. and Beijnen, J. H. 2009. Liquid chromatography- tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 269-276.
DOI
|
8 |
Wilhelm, S. and Chien, D. S. 2002. BAY 43-9006: preclinical data. Curr. Pharm. Des. 8, 2255-2257.
DOI
ScienceOn
|
9 |
Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M. and Lynch, M. 2008. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol. Cancer Ther. 7, 3129-3140.
DOI
ScienceOn
|
10 |
Zhao, M., Rudek, M. A., He, P., Hafner, F. T., Radtke, M., Wright, J. J., Smith, B. D., Messersmith, W. A., Hidalgo, M. and Baker, S. D. 2007. A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 846, 1-7.
DOI
|